RodrÃguez-Miguel, A.; Fernández-Fernández, B.; Ortiz, A.; Gil, M.; RodrÃguez-MartÃn, S.; Ruiz-Hurtado, G.; Fernández-Antón, E.; Ruilope, L.M.; de Abajo, F.J.
Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study. Pharmaceuticals 2024, 17, 1299.
https://doi.org/10.3390/ph17101299
AMA Style
RodrÃguez-Miguel A, Fernández-Fernández B, Ortiz A, Gil M, RodrÃguez-MartÃn S, Ruiz-Hurtado G, Fernández-Antón E, Ruilope LM, de Abajo FJ.
Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study. Pharmaceuticals. 2024; 17(10):1299.
https://doi.org/10.3390/ph17101299
Chicago/Turabian Style
RodrÃguez-Miguel, Antonio, Beatriz Fernández-Fernández, Alberto Ortiz, Miguel Gil, Sara RodrÃguez-MartÃn, Gema Ruiz-Hurtado, Encarnación Fernández-Antón, Luis M. Ruilope, and Francisco J. de Abajo.
2024. "Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study" Pharmaceuticals 17, no. 10: 1299.
https://doi.org/10.3390/ph17101299
APA Style
RodrÃguez-Miguel, A., Fernández-Fernández, B., Ortiz, A., Gil, M., RodrÃguez-MartÃn, S., Ruiz-Hurtado, G., Fernández-Antón, E., Ruilope, L. M., & de Abajo, F. J.
(2024). Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study. Pharmaceuticals, 17(10), 1299.
https://doi.org/10.3390/ph17101299
